Fierce Biotech May 8, 2024
Johnson & Johnson MedTech’s Biosense Webster division is rolling out a new version of its heart-mapping system that the company says marks its first to employ artificial intelligence capabilities.
The latest Carto 3 platform taps machine learning algorithms to help build three-dimensional models of the heart’s anatomy, charting out the structure of the left atrium to help guide surgeons through cardiac ablation and treat abnormal rhythms such as atrial fibrillation.
The new Cartosound FAM software module, cleared by the FDA, relies on an intracardiac ultrasound catheter to automatically generate images of the anatomy during its insertion procedure.
Biosense Webster also added the Elevate module, which incorporates electrophysiology features such as the automatic tracking of arrhythmias before and after delivering...
Today's Sponsors
Today's Sponsor